SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoca-Cola HBC Regulatory News (CCH)

Share Price Information for Coca-Cola HBC (CCH)

Share Price is delayed by 15 minutes
Get Live Data
4,612.00    26.00 (0.57%)
Bid:
4,612.00
Ask:
4,614.00
Spread: 2.00 (0.043%)
Market Cap: £16.81b
CCH Live PriceLast checked at - London Stock Exchange

Intraday Coca-Cola HBC Share Chart

CCH - Board Committees Composition

17 May 2023 15:44

RNS Number : 7744Z
Coca-Cola HBC AG
17 May 2023
 

 

Coca-Cola HBC AG

Composition of the Committees of the Board of Directors of Coca-Cola HBC AG

 

 

Zug, Switzerland - 17 May 2023 - Coca-Cola HBC AG ("Coca-Cola HBC" or the "Company") announces today that following the election of the board members at the AGM the composition of the Board Committees will be as follows:

 

Audit and Risk Committee

William W. (Bill) Douglas (Chair) 

 

Olusola (Sola) David-Borha 

 

Alexandra Papalexopoulou

Nomination Committee

Reto Francioni (Chair)

 

Charlotte J. Boyle 

 

Anna Diamantopoulou

Remuneration Committee

Charlotte J. Boyle (Chair) 

 

Reto Francioni

 

Anna Diamantopoulou

Social Responsibility Committee 

Anastasios I. Leventis (Chair)

 

Anna Diamantopoulou

 

Evguenia (Jeny) Stoitchkova

 

This announcement is made pursuant to the Financial Conduct Authority's Listing Rule 9.6.11R and there are no other matters that require disclosure under Listing Rule 9.6.13R.

 Coca‑Cola HBC Group

Investor and Analysts:

John Dawson 

Head of Investor Relations

Tel: +44 7522 619509

 john.dawson@cchellenic.com

 

Jemima Benstead

Investor Relations Manager

Tel: +44 7740 535130

jemima.benstead@cchellenic.com

 

Marios Matar

Investor Relations Manager

Tel: +30 697 444 3335

marios.matar@cchellenic.com

 

Virginia Phillips

Investor Relations Manager

 

Tel: +44 (0) 7864 686582

virginia.phillips@cchellenic.com

 

 

Media:

 

Sonia Bastian

Head of Communications

Tel: +41 7946 88054

sonia.bastian@cchellenic.com

 

 

 

 

 

About Coca‑Cola HBC

Coca-Cola HBC is a growth-focused consumer packaged goods business and strategic bottling partner of The Coca-Cola Company. We create value for all our stakeholders by supporting the socio-economic development of the communities in which we operate, and we believe building a more positive environmental impact is integral to our future growth. Together, we and our customers serve 715 million consumers across a broad geographic footprint of 29 countries on three continents. Our portfolio is one of the strongest, broadest and most flexible in the beverage industry, offering consumer-leading beverage brands in the sparkling, juice, water, sport, energy, plant-based, ready-to-drink tea, coffee, adult sparkling and premium spirits categories. These beverages include Coca-Cola, Coca-Cola Zero, Schweppes, Kinley, Costa Coffee, Valser, Römerquelle, Fanta, Sprite, Powerade, FuzeTea, Dobry, Cappy, Monster and Adez. We foster an open and inclusive work environment amongst our 33,000 employees and we are ranked among the top sustainability performers in ESG benchmarks such as the Dow Jones Sustainability Indices, CDP, MSCI ESG and FTSE4Good.

Coca-Cola HBC has a premium listing on the London Stock Exchange (LSE: CCH) and is listed on the Athens Exchange (ATHEX: EEE). For more information, please visit https://www.coca-colahellenic.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCARMITMTIBBTJ
Date   Source Headline
17th Dec 20187:27 amRNSTransaction in Own Shares
14th Dec 20187:14 amRNSTransaction in Own Shares
13th Dec 201811:37 amRNSHolding(s) in Company
13th Dec 20187:16 amRNSTransaction in Own Shares
12th Dec 20187:13 amRNSTransaction in Own Shares
11th Dec 20187:11 amRNSTransaction in Own Shares
10th Dec 20187:13 amRNSTransaction in Own Shares
7th Dec 20187:15 amRNSTransaction in Own Shares
6th Dec 20187:09 amRNSTransaction in Own Shares
5th Dec 20187:13 amRNSTransaction in Own Shares
4th Dec 20187:14 amRNSTransaction in Own Shares
3rd Dec 201812:44 pmRNSIssue of equity and total voting rights
3rd Dec 20187:19 amRNSCommencement of share purchase programme
19th Nov 20183:17 pmRNSDirector/PDMR Shareholding
19th Nov 201812:36 pmRNSDirector/PDMR Shareholding
8th Nov 20187:00 amRNSA QUARTER OF SOLID GROWTH
18th Oct 20182:36 pmRNSDirector/PDMR Shareholding
11th Oct 20181:35 pmRNSNotice of Results
19th Sep 201810:26 amRNSDirector/PDMR Shareholding
3rd Sep 201812:26 pmRNSIssue of equity and total voting rights
20th Aug 201811:45 amRNSDirector/PDMR Shareholding
9th Aug 20187:00 amRNSSTRONG VOLUME GROWTH DELIVERS GOOD RESULTS
1st Aug 20189:48 amRNSIssue of equity and total voting rights
26th Jul 20182:25 pmRNSDirector/PDMR Shareholding
18th Jul 201811:44 amRNSDirector/PDMR Shareholding
5th Jul 20183:46 pmRNSNotice of Results
2nd Jul 201810:13 amRNSIssue of equity and total voting rights
18th Jun 20181:42 pmRNSDirector/PDMR Shareholding
11th Jun 20183:20 pmRNSComposition of the Committees of the BoD of CCHBC
11th Jun 20182:35 pmRNSResult of AGM
1st Jun 201810:05 amRNSIssue of equity and total voting rights
18th May 20181:06 pmRNSDirector/PDMR Shareholding
15th May 20181:11 pmRNSDirector/PDMR Shareholding
15th May 20181:01 pmRNSDirector/PDMR Shareholding
15th May 201812:44 pmRNSDirector/PDMR Shareholding
10th May 20187:00 amRNSCONTINUING TO DELIVER BALANCED REVENUE GROWTH
8th May 201810:01 amRNSNotice of AGM
8th May 20189:20 amRNSChange to Board and dividend dates
4th May 20181:31 pmRNSAthens Exchange trading date of ordinary shares
1st May 20189:52 amRNSBlock listing Interim Review
1st May 20189:42 amRNSIssue of equity and total voting rights
18th Apr 20182:23 pmRNSDirector/PDMR Shareholding
13th Apr 20182:27 pmRNSNotice of Results
3rd Apr 201810:31 amRNSIssue of equity and total voting rights
19th Mar 20182:54 pmRNSDirector/PDMR Shareholding
16th Mar 20182:41 pmRNSDirector/PDMR Shareholding
16th Mar 20189:07 amRNSAnnual Financial Report
9th Mar 20184:03 pmRNSDirector/PDMR Shareholding
1st Mar 201812:32 pmRNSIssue of equity and total voting rights
27th Feb 20181:05 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.